Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients

European Journal of Haematology

Volumn 77, Issue 2, 2006, Pages 109-113

  Marotta, Giuseppe ^a,h   Frassoldati, Antonio ^b   Zinzani, Pierluigi ^c   Annino, Luciana ^d   Brugiatelli, Maura ^e   Ambrosetti, Achille ^f   Lenoci, Mariapia ^a   Federico, Massimo ^b   Foa, Robin ^g   Lauria, Francesco ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Hematology Unit   (Italy)

^e Hematology Unit   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

2 deoxycoformycin; Hairy cell leukemia; Interferon alpha

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; PARACETAMOL; PENTOSTATIN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRY SKIN; FEMALE; FEVER; FLU LIKE SYNDROME; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL RESPONSE MODIFIERS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERFERON ALFA-2B; ITALY; LEUKEMIA, HAIRY CELL; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PENTOSTATIN; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745713672     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00670.x     Document Type: Article

References (18)

1. BOURONCLE BA. Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 1979;53:412-436.
2. GOLOMB HM, JACOBS A, FEFER A, et al. Alpha 2 interferon therapy of hairy cell leukemia: a multicenter study of 64 patients. J Clin Oncol 1986;4:900-905.
3. SPIERS AS, MOORE D, CASSILETH PA, HARRINGTON DP, CUMMINGS FJ, NEIMAN RS, BENNET JM, O'CONNELL MJ. Remission in hairy cell leukemia with pentostatin (2′deoxycoformycin). N Eng J Med 1987;316:825-830.
4. HOFFMAN MA, JANSON D, ROSE E, RAI KR. Treatment of hairy cell leukemia with cladribine: response, toxicity, and long-term follow-up. J Clin Oncol 1997;15:1138-1142.
5. AHMED S, RAI KR. Interferon in the treatment of hairy cell leukemia. Best Pract Res Clin Hematol 2003;16:69-81.
6. CATOVSKY D, MATUTES E, TALAVERA JG, O'CONNOR NT, JOHNSON SA, EMMETT E, CORBETT L, SWANSBURY J. Long term results with 2′deoxycophormycin in hairy cell leukemia. Leuk Lymphoma 1994;14:109-113.
7. KAPLAN EL, MEIER P. Non-parametric estimation from incomplete observation. J Am Stat Ass 1958;53:457-463.
8. PETO R, PIKE MC, ARMITAGE P, BRESLOW NE, COX DR, HOWARD SV, MANTEL N, MCPHERSON K, PETO J, SMITH PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patients. Analyses and examples. Br J Cancer 1977;35:1-39.
9. LAURIA F, RONDELLI D, ZINZANI PL, BOCCHIA M, MAROTTA G, SALVUCCI M, RASPADORI D, VENTURA MA, BIRTOLO S, FORCONI F, TURA S. Long-lasting complete remission in patients with hairy cell leukemia treated with 2 CdA: a 5-year survey. Leukemia 1997;11:629-632.
10. DEARDEN CE, MATUTES E, HILDITCH BL, SWANSBURY GJ, CATOVSKY D. Long-term follow-up of patients with hairy cell leukemia after treatment with pentostatin or cladribine. Br J Haematol 1999;106:515-519.
11. CASSILETH PA, CHEUVART B, SPIERS AS, HARRINGTON DP, CUMMINGS FJ, NEIMAN RS, BENNET JM, O'CONNELL MJ. Pentostatin induces durable remissions in hairy cell leukemia. J Clin Oncol 1991;9:243-246.
12. KRAUT EH, BOURONCLE BA, GREVER MR et al. Low-dose deoxycophormycin in the treatment of hairy cell leukemia. Blood 1986;68:1119-1122.
13. QUESADA JR, HERSH EM, MANNING J, REUBEN J, KEATING M, SCHNIPPER E, ITRI L, GUTTERMAN JU. Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood 1986;68:493-497.
14. SMITH JW II, LONGO DL, URBA WJ, et al. Prolonged continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha-2a. Blood 1991;78:1664-1671.
15. CAPNIST G, FEDERICO M, CHISESI T, et al. Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL). Leuk Lymphoma 1994;14:457-464.
16. RAI KR, DAVEY F, PETERSON B, SCHIFFER C, SILVER RT, OZER H, GOLOMB H, BLOOMFIELD CD. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up result of study by Cancer and Leukemia Group B. Leukemia 1995;9:1116-1120.
17. SEMENZATO G, PIZZOLO G, AGOSTINI C, et al. Alpha interferon activates natural killer system in patients with hairy cell leukemia. Blood 1986;68:293-296.
18. VOKES EE, BITTER MA, RATAIN MJ, PRYSTOWSKY MB, DALY K, GOLOMB HM. Flow cytometry in hairy cell leukemia before and during interferon alpha 2b therapy. Cancer 1987;59:1987-1991.